Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-Health Disparities Subcommittee (HDS), 62635-62636 [2013-24338]

Download as PDF Federal Register / Vol. 78, No. 204 / Tuesday, October 22, 2013 / Notices line. Public comments received by close of business one week prior to each teleconference will be distributed to the NBSB in advance. Dated: September 30, 2013. Nicole Lurie, Assistant Secretary for Preparedness and Response. [FR Doc. 2013–24620 Filed 10–21–13; 8:45 am] BILLING CODE 4150–28–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Subcommittee on Procedures Review, Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH) sroberts on DSK5SPTVN1PROD with FRONT MATTER In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned subcommittee: Time and Date: 11:00 a.m.–5:00 p.m. Eastern Time, November 7, 2013. Place: Audio Conference Call via FTS Conferencing. The USA toll-free, dial-in number is 1 (866) 659–0537 and the pass code is 9933701. Status: Open to the public, but without a public comment period. The instructions for the submission of written comments are provided in the section entitled ‘‘MATTERS TO BE DISCUSSED.’’ To access by conference call dial the following information 1 (866) 659–0537, Participant Pass Code 9933701. Background: The ABRWH was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the compensation program. Key functions of the ABRWH include providing advice on the development of probability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the ABRWH to HHS, which subsequently delegated this authority to CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2015. VerDate Mar<15>2010 21:08 Oct 21, 2013 Jkt 232001 Purpose: The ABRWH is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is a reasonable likelihood that such radiation doses may have endangered the health of members of this class. The Subcommittee on Procedures Review was established to aid the ABRWH in carrying out its duty to advise the Secretary, HHS, on dose reconstructions. The Subcommittee on Procedures Review is responsible for overseeing, tracking, and participating in the reviews of all procedures used in the dose reconstruction process by the NIOSH Division of Compensation Analysis and Support (DCAS) and its dose reconstruction contractor (Oak Ridge Associated Universities—ORAU). Matters To Be Discussed: The agenda for the Subcommittee meeting includes discussion of the following ORAU and DCAS procedures: ORAU Team Technical Information Bulletin (OTIB) 054 (‘‘Fission and Activation Product Assignment for Internal Dose-Related Gross Beta and Gross Gamma Analyses’’), Program Evaluation Report (PER) 011 (‘‘K–25 TBD and TIB Revisions’’), PER 014 (‘‘Construction Trades Workers’’), PER 020 (‘‘Blockson TBD Revision’’), PER 25 (‘‘Huntington Pilot Plant TBD Revision’’), PER 030 (‘‘Savannah River Site TBD Revisions’’), PER 031 (‘‘Y–12 TBD Revisions’’), PER 033 (‘‘Reduction Pilot Plant TBD Revision’’), PER 038 (‘‘Hooker Electrochemical TBD Revisions’’); Update on Review of ORAU Team Report 0053 (‘‘Stratified Co-Worker Sets); estimating radiation doses associated with localized skin exposures to uranium at Atomic Weapons Employer facilities; International Commission on Radiological Protection Publication 116 (‘‘Conversion Coefficients for Radiological Protection Quantities for External Radiation Exposures’’); and a continuation of the comment-resolution process for other dose reconstruction procedures under review by the Subcommittee. The agenda is subject to change as priorities dictate. This meeting is open to the public, but without a public comment period. In the event an individual wishes to provide comments, written comments may be submitted. Any written comments received will be provided at the meeting and should be submitted to the contact person below in advance of the meeting. Contact Person for More Information: Theodore Katz, Designated Federal Official, NIOSH, CDC, 1600 Clifton Road, Mailstop E–20, Atlanta GA 30333, Telephone (513) 533–6800, Toll Free 1 (800) CDC–INFO, Email dcas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 62635 pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–24339 Filed 10–21–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention—Health Disparities Subcommittee (HDS) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned subcommittee: Time and Date: 9:00 a.m.–3:15 p.m. EDT, October 28, 2013. Place: CDC, Building 21, Room 1204A, 1600 Clifton Road NE., Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 20 people. The public is welcome to participate during the public comment, which is tentatively scheduled from 3:00 to 3:10 p.m. This meeting is also available by teleconference. Please dial (877) 496–4855 and enter code 4363556. Purpose: The Subcommittee will provide advice to the CDC Director through the ACD on strategic and other health disparities and health equity issues and provide guidance on opportunities for CDC. Matters To Be Discussed: The Health Disparities Subcommittee members will discuss some of the current health equity activities at CDC, as well as discuss health equity recommendations to the CDC ACD. The agenda is subject to change as priorities dictate. Web links: Connection-1: https:// wm.onlinevideoservice.com/CDC1. Mac/Flash Connection-3: https:// www.onlinevideoservice.com/clients/CDC/ ?mount=CDC3. Closed Caption is only available on the Windows Media link Connection-1. Viewer’s report is given the next day. Number for Technical Support: (404) 639–3737. Contact Person for More Information: Leandris Liburd, Ph.D., M.P.H., M.A., Designated Federal Officer, Health Disparities Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton Road NE., M/S K–77, Atlanta, Georgia 30333 Telephone (770) 488–8200, Email: LEL1@ cdc.gov. E:\FR\FM\22OCN1.SGM 22OCN1 62636 Federal Register / Vol. 78, No. 204 / Tuesday, October 22, 2013 / Notices The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 2013–24338 Filed 10–21–13; 8:45 am] BILLING CODE 4163–18–P Georgia 30333. Telephone (404) 639–4045. Email: hicpac@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–24341 Filed 10–21–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Healthcare Infection Control Practices Advisory Committee (HICPAC) sroberts on DSK5SPTVN1PROD with FRONT MATTER In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting for the aforementioned committee: Times and Dates: 9:00 a.m.–5:00 p.m., November 6, 2013; 9:00 a.m.–12:00 p.m., November 7, 2013. Place: Centers for Disease Control and Prevention, Global Communications Center, Building 19, Auditorium B3, 1600 Clifton Road NE., Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Please register for the meeting at www.cdc.gov/hicpac. Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion, the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health and Human Services regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters To Be Discussed: The agenda will include updates on CDC and Division of Healthcare Quality Promotion’s (DHQP’s) activities for prevention and surveillance of healthcare associated infections (HAI) and antimicrobial resistance, and developing a process to define core infection prevention and control methods. Also to be discussed is the development of guidance for CDC guideline recommendations that are categorized as ‘‘unresolved’’. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Erin Stone, M.S., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton Road NE., Mailstop A–07, Atlanta, 21:08 Oct 21, 2013 Jkt 232001 Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–24340 Filed 10–21–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifiers: CMS–10486] DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention VerDate Mar<15>2010 Prevention and the Agency for Toxic Substances and Disease Registry. Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Disease Control and Prevention ACTION: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Cooperative Agreement on Occupational Health with the World Health Organization (WHO): Implementing World Health Assembly Resolution 60.26 Global Plan of Action for Workers Health 2008–2017; RFA OH14–002. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 1:00 p.m.–4:00 p.m., December 10, 2013 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to Cooperative Agreement on Occupational Health with the World Health Organization (WHO): Implementing World Health Assembly Resolution 60.26 Global Plan of Action for Workers Health 2008– 2017; RFA OH14–002. Contact Person for More Information: Nina Turner, Ph.D., Scientific Review Officer, CDC, National Institute for Occupational Safety and Health, 1095 Willowdale Road, Morgantown, West Virginia 26506, Telephone: (304) 285–5976. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Notice. The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments on the collection(s) of information must be received by the OMB desk officer by November 21, 2013. SUMMARY: When commenting on the proposed information collections, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be received by the OMB desk officer via one of the following transmissions: OMB, Office of Information and Regulatory Affairs, Attention: CMS Desk Officer, Fax Number: (202) 395–6974 or Email: OIRA_submission@omb.eop.gov. ADDRESSES: E:\FR\FM\22OCN1.SGM 22OCN1

Agencies

[Federal Register Volume 78, Number 204 (Tuesday, October 22, 2013)]
[Notices]
[Pages 62635-62636]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-24338]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee to the Director (ACD), Centers for Disease 
Control and Prevention--Health Disparities Subcommittee (HDS)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
subcommittee:

    Time and Date: 9:00 a.m.-3:15 p.m. EDT, October 28, 2013.
    Place: CDC, Building 21, Room 1204A, 1600 Clifton Road NE., 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 20 people. The public is 
welcome to participate during the public comment, which is 
tentatively scheduled from 3:00 to 3:10 p.m. This meeting is also 
available by teleconference. Please dial (877) 496-4855 and enter 
code 4363556.
    Purpose: The Subcommittee will provide advice to the CDC 
Director through the ACD on strategic and other health disparities 
and health equity issues and provide guidance on opportunities for 
CDC.
    Matters To Be Discussed: The Health Disparities Subcommittee 
members will discuss some of the current health equity activities at 
CDC, as well as discuss health equity recommendations to the CDC 
ACD.
    The agenda is subject to change as priorities dictate.
    Web links: Connection-1: https://wm.onlinevideoservice.com/CDC1.
    Mac/Flash Connection-3: https://www.onlinevideoservice.com/clients/CDC/?mount=CDC3.
    Closed Caption is only available on the Windows Media link 
Connection-1. Viewer's report is given the next day. Number for 
Technical Support: (404) 639-3737.
    Contact Person for More Information: Leandris Liburd, Ph.D., 
M.P.H., M.A., Designated Federal Officer, Health Disparities 
Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton 
Road NE., M/S K-77, Atlanta, Georgia 30333 Telephone (770) 488-8200, 
Email: LEL1@cdc.gov.

[[Page 62636]]

    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 2013-24338 Filed 10-21-13; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.